KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Sep 2025 value amounting to $14.3 billion.

  • Vertex Pharmaceuticals' Non-Current Assets rose 14.93% to $14.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 billion, marking a year-over-year increase of 14.93%. This contributed to the annual value of $12.9 billion for FY2024, which is 50.67% up from last year.
  • Vertex Pharmaceuticals' Non-Current Assets amounted to $14.3 billion in Q3 2025, which was up 5.03% from $13.6 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Non-Current Assets registered a high of $14.3 billion during Q3 2025, and its lowest value of $3.6 billion during Q1 2021.
  • In the last 3 years, Vertex Pharmaceuticals' Non-Current Assets had a median value of $11.2 billion in 2024 and averaged $10.6 billion.
  • In the last 5 years, Vertex Pharmaceuticals' Non-Current Assets dropped by 2.00% in 2021 and then soared by 76.89% in 2024.
  • Vertex Pharmaceuticals' Non-Current Assets (Quarterly) stood at $3.9 billion in 2021, then rose by 26.97% to $4.9 billion in 2022, then skyrocketed by 74.65% to $8.6 billion in 2023, then spiked by 50.67% to $12.9 billion in 2024, then grew by 14.93% to $14.3 billion in 2025.
  • Its Non-Current Assets stands at $14.3 billion for Q3 2025, versus $13.6 billion for Q2 2025 and $12.9 billion for Q1 2025.